Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Global Hypopituitary Control and Complications Study

NCT01088399 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01088399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01088399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Global Hypopituitary Control and Complications Study
Lead sponsor
Eli Lilly and Company
Phase
Observational
Overall status
Completed
Start date
September 30, 2002
Completion date
December 31, 2012
Enrollment
10,673 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency, adult, hypopituitarism, pituitary insufficiency